Summary of Purpose
This pilot phase will determine the feasibility of enrolment of patients to a stroke prevention trial within 24 hours of symptom onset and to assess the occurrence of adverse events and laboratory safety of early treatment initiation.Read More →
The following dates are available for this trial. Trial information last updated on 5 August 2008.
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Canadian Stroke Consortium, Canadian Stroke Network, Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada, Ministry of Health and Long-Term Care Ontario, Merck Research Laboratories.
Multi-center, randomized, double-blind, controlled trial, 2x2 factorial design.
Study Director: James Kennedy Nuffield Dept of Clinical Medicine, University of Oxford Phone: +1 (403) 944 4189 Email: email@example.com Email: firstname.lastname@example.org@ndm.ox.ac.uk